Xcout Intel
NeuroEM Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to NeuroEM Therapeutics, Inc. among medical device companies — ranked by similarity to what NeuroEM Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see NeuroEM Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About NeuroEM Therapeutics, Inc.
NeuroEM Therapeutics develops non-invasive medical technology to treat Alzheimer's disease. The company utilizes Transcranial Electromagnetic Treatment with Radio Frequencies (TEMT-RF) to target toxic brain proteins associated with cognitive decline in patients.
NeuroEM Therapeutics, Inc. at a glance
NeuroEM Therapeutics, Inc. is a medical device company headquartered in United States. Its most recent funding round, Series A, raised $1.3M in June 2025. Xcout tracks 9 named people at NeuroEM Therapeutics, Inc., including Chuck Papageorgiou (Chief Executive & Technical Officer).
NeuroEM Therapeutics, Inc. leadership
- Chuck PapageorgiouChief Executive & Technical Officer
- Edward Goodwin, PhDChief Science Officer
- Rob BaranowskiChief Engineer
- Sam Alex MulderChief of Staff
- Tracy IngramChief Operating & Information Officer
- William Scott Burgin, MDChief Medical Officer
3 more named people on record for NeuroEM Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
NeuroEM Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $1.3M | 2 named | |
| SEC Form D filing | $1.9M | — | |
| Series A | $2M | 1 named | |
| SEC Form D filing | $360,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 NeuroEM Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to NeuroEM Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Devices
NeuroThera develops a clinical-grade transcranial photobiomodulation platform that delivers near-infrared laser light to targeted brain regions. The company's non-invasive technology aims to treat major neurological and psychiatric conditions, including major depressive disorder, Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke recovery.
Medical Devices
NeuroReform Holdings develops the NeuroReformer, an FDA-cleared Class II medical device that uses patented scanning technology to measure individual patient frequencies and deliver personalized neuromuscular stimulation during movement. The company serves healthcare professionals across physical therapy, sports medicine, chiropractic, podiatry, and wellness sectors through a monthly lease model.
Medical Devices
NeuroGlove, LLC develops a novel medical device designed to treat a variety of neurological and psychological conditions, including stroke, Parkinson's disease, PTSD, traumatic brain injury, anxiety, depression, and insomnia. The company serves patients and healthcare sectors by providing innovative treatment options aimed at transforming healthcare.
Medical Devices
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
Medical Devices
Cognition Med, LLC develops interventional neurovascular medical devices designed to treat stroke patients through minimally-invasive endovascular procedures. The company focuses on creating technologies to remove blood clots from blood vessels in the brain.
Medical Devices
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Medical Devices
Galvanize Therapeutics, Inc. is a medical technology company focused on developing energy-based therapies to treat chronic diseases.
Medical - Devices
NeuroOne Medical Technologies Corporation is a publicly traded medical technology company headquartered in Eden Prairie, Minnesota, focused on diagnostic and therapeutic technologies.
Medical Devices
Motif Neurotech is a medical equipment and therapeutic brain-computer interface company headquartered in Houston, Texas. The company develops minimally invasive bioelectronic devices designed to provide therapeutic relief for mental health disorders.
Medical Devices
NeuroStar provides advanced, non-invasive transcranial magnetic stimulation (TMS) treatments designed for patients suffering from depression. The company is headquartered in Malvern, Pennsylvania, and offers physician-recommended in-office therapy.
Medical Devices
EndoStream Medical develops medical devices for the treatment of brain aneurysms, specifically focusing on intrasaccular flow diversion. The company's flagship product, the Nautilus Intrasaccular System, uses self-conforming scaffolds designed to promote thrombosis, enhance coil stability, and enable progressive occlusion for patients. The company serves the neurovascular medical sector.
Medical Devices
Route 92 Medical is a privately held medical technology company based in San Mateo, California. The company is dedicated to improving patient outcomes through revolutionary procedural changes and advanced neurovascular intervention tools.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of NeuroEM Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for NeuroEM Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →